Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cerus Corp (NASDAQ:CERS)

During the Trading Day
5.67 -0.05 / -0.87%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.67 -0.0018 / -0.03%
Volume: 43.9K
Health Technology
Medical Specialties

Company Description

Cerus Corp. is a biomedical products company, which is engaged in developing and commercializing the INTERCEPT blood system. It currently markets and sells the INTERCEPT blood system for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Contact Information

Cerus Corp.
2550 Stanwell Drive
Concord California 94520
P:(925) 288-6000
Investor Relations:
(925) 288-6319



Other institutional42.81%
Individual stakeholders4.96%
Mutual fund holders28.71%

Top Executives

William Mariner GreenmanPresident, Chief Executive Officer & Director
Suzanne MargerumVice President-Manufacturing & Operations
Kevin Dennis GreenChief Financial Officer & Vice President
Laurence M. CorashDirector, Chief Scientific Officer & Senior VP
Adonis StassinopoulosVP-Global Scientific Affairs & Research